- Home
- Equipment
- usa maryland
- eia test kit
Eia Test Kit Equipment Supplied In Usa Maryland
7 equipment items found
Premium
Manufactured by:Bertin Technologies based inMontigny-le-Bretonneux, FRANCE
The enzymatic immunoassay (ELISA) is based on the competition between unlabelled LEAP-2 and Biotin labelled LEAP-2 for limited specific rabbit anti-LEAP-antiserum sites. The complex rabbit antiserum – LEAP-2 (free LEAP-2 or Labelled) binds to the mouse monoclonal anti-rabbit antibody coated in the well. After the washing step, the complex binds to the mouse monoclonal ...
by:Hemagen Diagnostics, Inc. based inColumbia, MARYLAND (USA)
Designed for the semi-quantitative measurement of C-reactive protein (CRP) in human serum and plasma. 66203 - 96 Determinations Kit - Methodology EIA 66204 - 960 Determinations Kit, 10 x 96 Well - Methodology ...
by:Hemagen Diagnostics, Inc. based inColumbia, MARYLAND (USA)
For the detection of circulating antibodies to Trypanosoma cruzi, the causative agent of Chagas' disease66101 - 96 Determinations Kit - Methodology ...
by:Hemagen Diagnostics, Inc. based inColumbia, MARYLAND (USA)
An enzyme-linked immunosorbent assay (ELISA) designed for the quantitative measurement of circulating IgA autoantibodies to cardiolipin66015 - 480 Determinations Kit (5 x 96 Well) - Methodology EIA. 66025 - 96 Determinations Kit, Lyophilied Reagents - Methodology ...
Manufactured by:Maxim Biomedical based inRockville, MARYLAND (USA)
Maxim's FDA Approved HIV-1 Urine EIA test is an enzyme immunoassay for the in-vitro detection of antibodies to Human Immunodeficiency Virus Type 1 (HIV-1) in urine. The test is intended for use in professional laboratory settings as an aid in clinical diagnosis of HIV infection. Before a determination of HIV-1 status can be made, specimens that ...
Manufactured by:Maxim Biomedical based inRockville, MARYLAND (USA)
The Maxim HIV-1 Limiting Antigen-Avidity EIA is an in-vitro quantitative limiting antigen (LAg) avidity enzyme immunoassay for distinguishing recent HIV-1 infections from those which are long-term. Persons with recently acquired HIV-1 infections typically exhibit HIV-1 specific IgG populations with higher proportions of lower avidity IgG than those with long-term infections which typically ...
Manufactured by:Maxim Biomedical based inRockville, MARYLAND (USA)
The Maxim HIV-1 Limiting Antigen-Avidity Dried Blood Spot (DBS) EIA is an in-vitro quantitative limiting antigen (LAg) avidity enzyme immunoassay for distinguishing recent HIV-1 infections from those which are long-term. Persons with recently acquired HIV-1 infections typically exhibit HIV-1 specific IgG populations with higher proportions of lower avidity IgG than those with long-term infections ...